pexels steve johnson 2130474

What Can Biopharma Learn From Apple?

IN VIVO, January 2014 The restructuring of pharmaceutical R&D organizations has failed to address fundamental issues that afflict R&D across several industries. Most of this shortfall can be attributed to a dearth of effective leadership within the C-suites of the drug industry